Life situation among persons living with inflammatory bowel disease
نویسنده
چکیده
................................................................................................................... 1 LIST OF PAPERS .......................................................................................................... 3 ABBREVIATIONS ........................................................................................................ 4 ACKNOWLEDGEMENTS ............................................................................................ 5 INTRODUCTION .......................................................................................................... 7 BACKGROUND ............................................................................................................ 9 Historical background ................................................................................................. 9 Diagnosis ..................................................................................................................... 9 Course of the disease and symptoms ........................................................................ 10 Pathogenesis .............................................................................................................. 10 Epidemiology ............................................................................................................ 11 Associated health problems ...................................................................................... 11 Treatment .................................................................................................................. 11 Impact on life situation ............................................................................................. 12 Disease related knowledge ........................................................................................ 14 Quality of care ........................................................................................................... 16 Assessing quality of care .......................................................................................... 17 Rationale for this thesis ............................................................................................. 19 AIMS ............................................................................................................................. 20 General aim ............................................................................................................... 20 Specific aims ............................................................................................................. 20 METHOD...................................................................................................................... 21 Design ....................................................................................................................... 21 Overview of the studies ............................................................................................ 22 Study I ....................................................................................................................... 22 Study II ...................................................................................................................... 22 Study III .................................................................................................................... 22 Participants and sample size ..................................................................................... 23 Setting and procedure ............................................................................................... 23 Data Collection ......................................................................................................... 24 Demographic data ................................................................................................. 24 Interviews (I, II) .................................................................................................... 25 Study I ................................................................................................................... 25 Study II .................................................................................................................. 25 Questionnaire (III) ................................................................................................ 26 QoC-IBD ............................................................................................................... 26 Phase I – Question generation .............................................................................. 26 Phase II – Patients’ and professionals’ evaluation................................................ 27 Phase III Measurement evaluation ..................................................................... 28 QOUTE-IBD ......................................................................................................... 28 Data analysis ............................................................................................................. 29 Qualitative analysis (I, II) ..................................................................................... 29 Qualitative content analysis .................................................................................. 29 Critical incident techniques .................................................................................. 29 Focus group interviews ......................................................................................... 30 Statistical analysis ................................................................................................. 32 Ethical considerations ............................................................................................... 32 RESULTS ..................................................................................................................... 33 Characteristics of the participants ............................................................................. 33 When daily life becomes affected by symptom burden ............................................ 33 The importance of disease related knowledge .......................................................... 34 Being met with trust and respect ............................................................................... 35 Being an active part of healthcare decisions ............................................................. 36 Important aspects of quality of care .......................................................................... 38 DISCUSSION ............................................................................................................... 41 When daily life become affected by symptom burden ............................................. 41 The importance of disease related knowledge .......................................................... 41 Being met with trust and respect ............................................................................... 43 Being an active part of healthcare decisions ............................................................. 44 Important aspects of quality of care .......................................................................... 45 Methodological discussion........................................................................................ 46 Validity and reliability .......................................................................................... 46 Drop out and question non response study IV ...................................................... 48 Conclusions ............................................................................................................... 50 Clinical implication ................................................................................................... 50 Future research .......................................................................................................... 51 POPULÄRVETENSKAPLIG SAMMANFATTNING ............................................... 52 REFERENCES ............................................................................................................. 54
منابع مشابه
Comparison of Coping Strategies in People with Inflammatory Bowel Disease and Healthy People in Terms of Health Locus of Control
Background: Inflammatory bowel disease (IBD) is a group of disorders that cause chronic inflammation (pain and swelling) in the intestines. IBD includes Crohn’s disease and ulcerative colitis. Both types affect the digestive system. The study aims to compare coping strategies in people with inflammatory bowel disease and healthy people, according to internal and external sources of health contr...
متن کاملThe biopsychosocial model of treatment the patients with inflammatory chronic bowel disease.
We present the organised psychological group interventions for persons with inflammatory bowel disease (ulcerose colitis, Morbus Crohn). The actual bio-psychosocial model of health and illness is used to explain the situation of chronically ill patient as stressful life position and their ways of coping with such, health-related problems. Considering that numerous psychological factors can lead...
متن کاملEffects of Probiotics and Prebiotics in Inflammatory Bowel Disease
Inflammatory bowel diseases (IBD) including most important forms; Crohn’s disease (CD) and ulcerative colitis (UC); are chronic diseases affecting the gastrointestinal tract with unclear etiology and pathology. The role of gut microbiota has recently been considered as major a factor, since altered microbiome or "dysbiosis" is a key player in the protracted course of inflammation in IBD. Howeve...
متن کاملValidation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients
Abstract Background: Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine that may have critical consequences on patient’s quality of life (QOL). Many disease-specific QOL tools have been developed recently. The McMaster Inflammatory Bowel Disease Questionnaire (IBDQ) is one of them. The aim of this study was to translate into Persian and eval...
متن کاملPneumococcal Vaccination Rates in VHA Patients With Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an inflammatory condition of the digestive tract not caused by infectious agents. Symptoms of IBD, such as diarrhea and pain, diminish one's quality of life. Underlying immune dysregulation may put IBD patients at risk for severe infectious disease making preventative vaccination highly recommended. Therefore, this study sought to assess rates of pneumococcal...
متن کامل